Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Apollo Endosurgery, Inc. (APEN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.55+0.14 (+2.59%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.41
Open5.42
Bid5.52 x 900
Ask7.30 x 1000
Day's Range5.42 - 5.74
52 Week Range3.49 - 10.39
Volume61,928
Avg. Volume344,828
Market Cap219.183M
Beta (5Y Monthly)2.27
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    MIMEDX Announces Leadership Transition

    K. Todd Newton Appointed as Interim Chief Executive Officer, Replacing Timothy R. Wright, Effective Immediately MARIETTA, Ga., Sept. 06, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that K. Todd Newton, a member of the MIMEDX Board of Directors, has been appointed interim Chief Executive Officer (CEO). Mr. Newton replaces Timothy R. Wright, who served as MIMEDX’s CEO since May of 2019. M. K

  • ACCESSWIRE

    Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami

    Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced that the endoscopic sleeve gastroplasty (ESG) procedure was featured in a 2022 Top 10 Paper at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 2022 World Congress, held August 23-27 in Miami.

  • ACCESSWIRE

    Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022

    Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2022 and recent corporate highlights.

Advertisement
Advertisement